The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Effects of short‐term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo‐controlled trial
Open accessAbstract
Abstract.: Objectives. The UK Prospective Diabetes Study (UKPDS) showed that treatment with metformin decreases macrovascular morbidity and mortality independent of glycaemic control. We hypothesized that metformin may achieve this by improving endothelial function and chronic, low‐grade inflammation. Data on this issue are scarce and we therefore tested, in the setting of a randomized, placebo‐controlled trial, whether metformin can affect endothelial function and low‐grade inflammation. Design. The Hyperinsulinaemia the Outcome of its Metabolic Effects (HOME) trial is a double‐blind trial, in which all patients were randomized to receive either metformin or placebo in addition to insulin therapy. At the beginning and the end of a 16‐week treatment period fasting blood samples were drawn and a physical examination was carried out. Setting. The trial was conducted in the outpatient clinics of three nonacademic hospitals (Hoogeveen, Meppel and Coevorden; the Netherlands). Subjects. Patients were included if they were between 30 and 80 years of age; had received a diagnosis of diabetes after the age of 25; had never had an episode of ketoacidosis; and their blood glucose‐lowering treatment previously consisted of oral agents but now only consisted of either insulin (n = 345) or insulin and metformin (n = 45). We excluded pregnant women and women trying to become pregnant, patients with a Cockroft‐Gault‐estimated creatinine clearance <50 mL min−1, or low plasma cholinesterase (reference value <3.5 units L−1), patients with congestive heart failure (New York Heart Association class III/IV), or patients with other serious medical or psychiatric disease. A total of 745 eligible patients were approached; 390 gave informed consent and were randomized (196 metformin, 194 placebo). About 353 patients completed 16 weeks of treatment (171 metformin, 182 placebo). Main outcome measures. The HOME trial was designed to study the metabolic and cardiovascular effects of metformin during a follow‐up of 4 years. Presented here are the results of an interim analysis after 16 weeks of treatment. Results. When compared with placebo, metformin treatment was associated with an increase in urinary albumin excretion of 21% (−1 to +48; P = 0.06); a decrease in plasma von Willebrand factor of 6% (−10 to −2; P = 0.0007); a decrease in soluble vascular cell adhesion molecule‐1 of 4% (−7 to −2; P = 0.0002); a decrease in soluble E‐selectin of 6% (−10 to −2; P = 0.008); a decrease in tissue‐type plasminogen activator of 16% (−20 to −12; P < 0.0001); and a decrease in plasminogen activator inhibitor‐1 of 20% (−27 to −10; P = 0.0001). These changes could not be explained by metformin‐associated changes in glycaemic control, body weight or insulin dose. Markers of inflammation, i.e. C‐reactive protein and soluble intercellular adhesion molecule‐1, did not change with metformin treatment. Conclusions. In patients with type 2 diabetes treated with insulin, metformin treatment was associated with improvement of endothelial function, which was largely unrelated to changes in glycaemic control, but not with improvement of chronic, low‐grade inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Passing, H., & Bablok, W. (1983) · cclm · doi:10.1515/cclm.1983.21.11.709 · Cited by 1,513
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus
Mather, K. J., Verma, S., & Anderson, T. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01129-9 · Cited by 513
Charles, M. A., Morange, P., Eschwège, E., André, P., Vague, P., & Juhan-Vague, I. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1967 · Cited by 120
Research works printed but not linked: 45
- 10.1016/S0140-6736(98)07037-8 · DOI · Paper page
- 10.1056/NEJM199901143400207 · DOI · Paper page
- 10.2337/diabetes.51.4.1157 · DOI · Paper page
- 10.2337/diabetes.49.3.485 · DOI · Paper page
- 10.2337/diacare.16.4.621 · DOI · Paper page
- 10.2337/diacare.19.1.64 · DOI · Paper page
- 10.1046/j.1365-2362.1999.00497.x · DOI
- 10.2337/diacare.25.12.2133 · DOI · Paper page
- 10.1159/000180580 · DOI · Paper page
- 10.1016/0009-8981(95)06067-N · DOI
- 10.1046/j.1365-2796.2003.01213.x · DOI · Paper page
- Passing H, 1984, Comparison of several regression procedures for method comparison studies and determination of sample sizes: II. Application of linear regression procedures for method comparison studies in clinical chemistry, J Clin Chem Clin Biochem, 22, 431
- 10.1093/clinchem/43.10.1904 · DOI
- Scheffer PG, 1998, Measurement of LDL particle size in whole plasma and serum by high performance gel‐filtration chromatography using a fluorescent lipid probe, Clin Chem, 44, 2148, 10.1093/clinchem/44.10.2148 · DOI
- 10.1016/S0008-6363(96)00272-6 · DOI · Paper page
- 10.1161/01.ATV.18.9.1359 · DOI · Paper page
- Vapaatalo H, 2001, Clinically important factors influencing endothelial function, Med Sci Monit, 7, 1075
- 10.1161/hh2101.099270 · DOI · Paper page
- 10.1111/j.1464-5491.1991.tb01610.x · DOI
- 10.2337/diacare.25.12.2123 · DOI
- 10.1046/j.1464-5491.1999.00201.x · DOI
- 10.2337/diacare.21.6.1008 · DOI
- 10.2337/diacare.24.3.549 · DOI
- 10.1161/01.ATV.18.5.723 · DOI · Paper page
- 10.1161/hc4401.098490 · DOI · Paper page
- 10.1055/s-0037-1615401 · DOI
- 10.2337/diacare.21.12.2135 · DOI · Paper page
- 10.7326/0003-4819-130-5-199903020-00002 · DOI · Paper page
- 10.1016/S0188-4409(00)00241-1 · DOI
- 10.1007/BF00285287 · DOI · Paper page
- 10.1210/jc.2002-021688 · DOI · Paper page
- 10.1089/15209150050025230 · DOI
- 10.1016/S1262-3636(03)72796-7 · DOI
- 10.2337/diabetes.48.1.198 · DOI · Paper page
- 10.1016/S0006-2952(99)00263-4 · DOI · Paper page
- 10.1016/S0014-2999(99)00342-8 · DOI
- 10.2337/diacare.20.12.1863 · DOI
- 10.1210/jc.74.5.1020 · doi:10.1210/jc.74.5.1020
- 10.1016/S0006-291X(02)02464-6 · DOI
- 10.1053/meta.2002.31332 · DOI
- 10.1053/meta.2001.28078 · DOI · Paper page
- 10.2337/diabetes.52.3.667 · DOI · Paper page
- 10.1210/jc.2002-021193 · DOI
- 10.1055/s-2007-978682 · DOI
- 10.1055/s-2007-979059 · DOI
Cited by
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
Metformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,349
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Metadata
- Authors
- DE JAGER, J., KOOY, A., LEHERT, P., BETS, D., WULFFELÉ, M. G., TEERLINK, T., SCHEFFER, P. G., SCHALKWIJK, C. G., DONKER, A. J. M., & STEHOUWER, C. D. A.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2004-12-07
- Volume
- 257
- Issue
- 1
- Pages
- 100-109
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W1995897557
- Cited by
- 220
- References
- 5
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of short‐term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo‐controlled trial. https://app.cochat.ai/papers/10.1111/j.1365-2796.2004.01420.x
- The paper
- DE JAGER, J., KOOY, A., LEHERT, P., BETS, D., WULFFELÉ, M. G., TEERLINK, T., SCHEFFER, P. G., SCHALKWIJK, C. G., DONKER, A. J. M., & STEHOUWER, C. D. A. (2005). Effects of short‐term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo‐controlled trial. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.2004.01420.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.